BRUGIA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 2.765
EU - Europa 2.042
AS - Asia 1.582
SA - Sud America 126
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 43
OC - Oceania 18
Totale 6.649
Nazione #
US - Stati Uniti d'America 2.690
RU - Federazione Russa 686
IT - Italia 556
CN - Cina 458
SG - Singapore 445
PL - Polonia 230
HK - Hong Kong 223
IE - Irlanda 121
VN - Vietnam 113
KR - Corea 111
BR - Brasile 99
DE - Germania 86
SE - Svezia 83
FR - Francia 71
FI - Finlandia 62
IN - India 52
CA - Canada 45
JO - Giordania 44
AT - Austria 39
BD - Bangladesh 38
GB - Regno Unito 26
ID - Indonesia 26
JP - Giappone 22
NL - Olanda 20
AU - Australia 17
CH - Svizzera 17
MX - Messico 15
ZA - Sudafrica 15
ES - Italia 14
IQ - Iraq 10
PK - Pakistan 10
UA - Ucraina 9
AR - Argentina 8
TR - Turchia 8
UZ - Uzbekistan 7
NG - Nigeria 6
PH - Filippine 6
BE - Belgio 5
CL - Cile 4
DZ - Algeria 4
EC - Ecuador 4
MA - Marocco 4
PE - Perù 4
BJ - Benin 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
EG - Egitto 3
GT - Guatemala 3
NO - Norvegia 3
SV - El Salvador 3
VE - Venezuela 3
AL - Albania 2
GR - Grecia 2
JM - Giamaica 2
KE - Kenya 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CO - Colombia 1
CR - Costa Rica 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
IL - Israele 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
MQ - Martinica 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
UY - Uruguay 1
Totale 6.576
Città #
Santa Clara 592
Ashburn 456
Singapore 311
Warsaw 225
Hong Kong 189
San Jose 148
Chandler 123
Dublin 121
Hefei 113
Seoul 111
Fairfield 100
Florence 99
Milan 90
Beijing 83
Dallas 54
Houston 52
Los Angeles 52
Seattle 52
Cambridge 49
The Dalles 49
Council Bluffs 45
Woodbridge 45
Buffalo 43
Munich 43
New York 38
Wilmington 38
Vienna 37
Hanoi 33
Helsinki 33
Moscow 33
Altamura 32
Ho Chi Minh City 31
Paris 31
Rome 30
Lauterbourg 29
Lawrence 28
Shanghai 26
Ann Arbor 25
Tokyo 22
Boston 21
Jakarta 21
Mumbai 21
Bremen 20
Princeton 20
Turku 19
Kent 18
Bern 17
Boardman 17
Melbourne 16
Orem 14
São Paulo 13
Bologna 12
Medford 12
Pune 12
Clifton 11
Naples 11
Toronto 11
Johannesburg 10
Frankfurt am Main 9
Barcelona 8
Bengaluru 8
Brescia 8
Dong Ket 8
Lappeenranta 8
London 8
Atlanta 7
Brooklyn 7
Chicago 7
Montreal 7
North Charleston 7
Phoenix 7
Tashkent 7
Las Vegas 6
Turin 6
Vancouver 6
Venice 6
Brussels 5
Charlotte 5
Chennai 5
Denver 5
Falls Church 5
Guangzhou 5
Mexico City 5
Mosier 5
San Francisco 5
Shenzhen 5
Stockholm 5
Abuja 4
Amandola 4
Ancona 4
Bari 4
Can Tho 4
Cinisello Balsamo 4
Da Nang 4
Genoa 4
Haiphong 4
Hangzhou 4
Hải Dương 4
Miano 4
Nuremberg 4
Totale 4.244
Nome #
Emerging drugs in refractory colorectal cancer 335
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 293
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 251
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 242
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 241
Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer. 234
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect 232
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 232
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 228
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 207
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 205
Current status and future perspectives in HER2 positive advanced gastric cancer 203
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 203
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 199
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 197
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 193
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 193
Physical exercise and eating habits in cancer survivors 190
Somatostatin analogs in pregnant patients with neuroendocrine tumor 188
Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy 187
In Regard to "Activity of EGFR TKIs in Caucasian Patients With NSCLC Harbouring Potentially Sensitive Uncommon EGFR Mutations" 184
Results of the observational prospective RealFLOT study 184
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 183
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 181
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives 181
Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma 174
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI 169
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer 166
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO 158
Regorafenib also can cause osteonecrosis of the jaw 156
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer 139
Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: Results from the MAVERIC Phase II Trial (1499 WORDS MAIN TEXT) 123
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 94
Beneath the surface of colorectal cancer: Unmasking the evolving nature of (Neo)RAS 56
Immune checkpoint inhibitors in the first-line treatment of esophageal squamous cell carcinoma: Minireview for a big shift 48
Totale 6.649
Categoria #
all - tutte 19.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.809


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022127 0 0 5 3 2 10 1 20 11 13 16 46
2022/2023651 32 110 18 60 45 121 70 55 80 9 20 31
2023/2024398 9 25 37 18 20 62 25 81 8 34 34 45
2024/20251.991 63 175 111 330 503 265 30 123 106 74 92 119
2025/20262.530 329 304 245 215 301 94 293 112 136 177 75 249
2026/2027210 126 75 9 0 0 0 0 0 0 0 0 0
Totale 6.649